Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Akihiko Iwasawa"'
Autor:
Satoshi Takahashi, Hiroshi Kiyota, Shin Ito, Akihiko Iwasawa, Yoshiki Hiyama, Teruhisa Uehara, Koji Ichihara, Jiro Hashimoto, Naoya Masumori, Kenichi Sunaoshi, Koichi Takeda, Nobukazu Suzuki, Takahide Hosobe, Hirokazu Goto, Hidenori Suzuki, Shoichi Onodera
Publikováno v:
Antibiotics, Vol 3, Iss 2, Pp 109-120 (2014)
To clarify the clinical efficacy of a single oral 2 g dose of azithromycin extended-release for heterosexual male patients with urethritis, and the current antimicrobial sensitivity of Neisseria gonorrhoeae to azithromycin, a prospective clinical tri
Externí odkaz:
https://doaj.org/article/0a7c52f96f904945b841fb91a8bb8c70
Autor:
Naoya Masumori, Shintaro Miyamoto, Taiji Tsukamoto, Seiji Furuya, Akihiko Iwasawa, Takashi Sato, Naoki Itoh, Akihiko Shibuya, Toshiro Oda
Publikováno v:
Advances in Urology, Vol 2011 (2011)
Objectives. To prospectively examine the efficacy and safety of propiverine hydrochloride in patients with overactive bladder (OAB) symptoms who poorly responded to previous treatment with solifenacin, tolterodine or imidafenacin. Methods. Patients a
Externí odkaz:
https://doaj.org/article/de3f18a5bddc48d9a67bebe441bdee9b
Autor:
Masahiro Nishimura, Nobukazu Suzuki, Akihiko Iwasawa, Takaoki Hirose, Koji Ichihara, Naoya Masumori, Noriomi Miyao, Yasuhiro Yamaguchi, Hiroto Sasamura, Keisuke Taguchi, Kazunori Haga
Publikováno v:
International Journal of Urology. 25:849-854
OBJECTIVE To assess the efficacy of silodosin as second-line α-blocker monotherapy in patients with lower urinary tract symptoms as a result of benign prostatic hyperplasia. METHODS Men who were given an α-blocker other than silodosin for ≥8 week
Autor:
Shigeki Nakayama, Akihiko Iwasawa
Publikováno v:
Journal of Environmental Engineering (Transactions of AIJ). 79:181-189
Autor:
Taiji Tsukamoto, Akihiko Iwasawa, Naoya Masumori, Akihiko Shibuya, Noriomi Miyao, Yasuharu Kunishima
Publikováno v:
Patient preference and adherence
Naoya Masumori,1 Taiji Tsukamoto,1 Akihiko Shibuya,2 Noriomi Miyao,3 Yasuharu Kunishima,4 Akihiko Iwasawa5 1Department of Urology, Sapporo Medical University School of Medicine, Sapporo, 2Kaguraoka Urological Clinic, Asahikawa, 3Division of Urology,
Autor:
Akihiko Iwasawa, Shigeki Nakayama
Publikováno v:
Journal of Environmental Engineering (Transactions of AIJ). 77:925-932
Autor:
Shintaro Miyamoto, Toshiro Oda, Seiji Furuya, Akihiko Shibuya, Naoya Masumori, Taiji Tsukamoto, Takashi Sato, Akihiko Iwasawa, Naoki Itoh
Publikováno v:
Advances in Urology
Advances in Urology, Vol 2011 (2011)
Advances in Urology, Vol 2011 (2011)
Objectives. To prospectively examine the efficacy and safety of propiverine hydrochloride in patients with overactive bladder (OAB) symptoms who poorly responded to previous treatment with solifenacin, tolterodine or imidafenacin.Methods. Patients ag
Autor:
Nobukazu Suzuki, Satoshi Takahashi, Koh Takeyama, Taiji Tsukamoto, Kouichi Takeda, Yasuharu Kunishima, Akifumi Yokoo, Hitoshi Tanda, Toshiaki Tanaka, Mikio Koroku, Hiroki Horita, Masanori Matsukawa, Masahiro Nishimura, Akihiko Iwasawa, Takaoki Hirose
Publikováno v:
Journal of Infection and Chemotherapy. 14:137-140
Antimicrobial treatment is usually used for chronic prostatitis. However, the efficacy of such treatment has not been fully evaluated. We conducted a study to evaluate the efficacy of gatifloxacin for patients with chronic prostatitis using the Japan
Autor:
Naoya Masumori, Koji Ichihara, Fumimasa Fukuta, Akihiko Iwasawa, Taiji Tsukamoto, Yoshinori Tanaka
Publikováno v:
The Journal of urology. 193(3)
We evaluated the efficacy and safety of add-on treatment with a β3-adrenoceptor agonist (mirabegron) for overactive bladder symptoms remaining after α1-blocker (tamsulosin) treatment in men with benign prostatic obstruction.Patients with benign pro
Autor:
Jiro Hashimoto, Shin Ito, Nobukazu Suzuki, Teruhisa Uehara, Shoichi Onodera, Hidenori Suzuki, Koji Ichihara, Yoshiki Hiyama, Hirokazu Goto, Takahide Hosobe, Kenichi Sunaoshi, Akihiko Iwasawa, Hiroshi Kiyota, Koichi Takeda, Satoshi Takahashi, Naoya Masumori
Publikováno v:
Antibiotics
Volume 3
Issue 2
Pages 109-120
Antibiotics, Vol 3, Iss 2, Pp 109-120 (2014)
Volume 3
Issue 2
Pages 109-120
Antibiotics, Vol 3, Iss 2, Pp 109-120 (2014)
To clarify the clinical efficacy of a single oral 2 g dose of azithromycin extended-release for heterosexual male patients with urethritis, and the current antimicrobial sensitivity of Neisseria gonorrhoeae to azithromycin, a prospective clinical tri